Spire Healthcare Group PLC Director/PDMR Shareholding (1619B)
March 31 2017 - 3:40AM
UK Regulatory
TIDMSPI
RNS Number : 1619B
Spire Healthcare Group PLC
31 March 2017
31 March 2017
Spire Healthcare Group plc (the "Company")
Exercise of 2014 Long Term Incentive Plan award
On 30 March 2017, Simon Gordon, an Executive Director of the
Company, exercised his vested Long Term Incentive Plan award (the
"Award") over ordinary shares in the Company. The Award was
originally granted in the form of nil-cost options on 30 September
2014.
Performance conditions
The performance period for the Award ended on 31 December 2016.
The Award was based on targets linked to earnings per share (EPS)
and relative total shareholder return (TSR) performance.
Half of the Award was based on TSR performance measured against
the constituents of the FTSE 250 (excluding investment trusts).
Threshold vesting (25% of the element) required median performance,
with outperformance of the upper quartile required for full
vesting. Over the period to 31 December 2016, the Company delivered
a total shareholder return of +76%. This was well within the upper
quartile of the comparator group, and therefore this element of the
Award vested in full.
The remaining half of the award was based on EPS targets. The
2016 EPS was below the threshold of 20.6 pence, and therefore this
element of the Award lapsed in full.
Exercise of Award
Simon Gordon sold sufficient shares to cover his Income Tax and
NIC liabilities and then retained the balance of his Award.
Director Type of award Shares vested Shares Shareholding
and exercised sold* following
transaction
-------------- --------------- --------------- ------- -------------
Conditional
Share Award
(in the form
of nil-cost
Simon Gordon options) 124,113 58,539 537,332
-------------- --------------- --------------- ------- -------------
*All shares sold were at an average share price of 327.5829
pence.
Enquiries:
Philip Davies
Deputy Company Secretary
020 7427 9092
The following disclosure is made in accordance with Article 19
of the EU Market Abuse Regulation 596/2014.
1 Details of the person discharging managerial
responsibilities/person closely associated
---- --------------------------------------------------------------------
a) Name Simon Gordon
---- ------------------------ ------------------------------------------
2 Reason for the notification
---- --------------------------------------------------------------------
a) Position/status Executive Director and Chief Financial
Officer
---- ------------------------ ------------------------------------------
b) Initial notification Initial notification
/Amendment
---- ------------------------ ------------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- --------------------------------------------------------------------
a) Name Spire Healthcare Group plc
---- ------------------------ ------------------------------------------
b) LEI n/a
---- ------------------------ ------------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- --------------------------------------------------------------------
a) Description Ordinary shares of 1 pence each
of the financial
instrument,
type of instrument
Identification
code
---- ------------------------ ------------------------------------------
b) Nature of Exercise of a nil-cost share option
the transaction over 124,113 shares granted under
the Company's Long Term Incentive
Plan and subsequent sale of 58,539
shares to cover Income Tax and
NIC liabilities.
---- ------------------------ ------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s)
---- ------------------------ -------------------------- --------------
327.5829 pence 58,539
-------------------------------------------------------- --------------
d) Aggregated As above
information
- Aggregated
volume
- Price
---- ------------------------ ------------------------------------------
e) Date of the 2017-03-30
transaction
---- ------------------------ ------------------------------------------
f) Place of the XLON
transaction
---- ------------------------ ------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGIGDXGSXBGRB
(END) Dow Jones Newswires
March 31, 2017 04:40 ET (08:40 GMT)
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From Apr 2024 to May 2024
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From May 2023 to May 2024